# Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.

> **NCT01816672** · NA · TERMINATED · sponsor: **Cytomedix** · enrollment: 4 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** AutoloGel
- **OTHER:** Usual and Customary Care

## Key facts

- **NCT ID:** NCT01816672
- **Lead sponsor:** Cytomedix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816672, "Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01816672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*